0001104659-23-092107.txt : 20230815
0001104659-23-092107.hdr.sgml : 20230815
20230815202732
ACCESSION NUMBER: 0001104659-23-092107
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230811
FILED AS OF DATE: 20230815
DATE AS OF CHANGE: 20230815
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEIBOWITZ LAWRENCE E
CENTRAL INDEX KEY: 0001276505
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40949
FILM NUMBER: 231176270
MAIL ADDRESS:
STREET 1: C/O NYSE EURONEXT
STREET 2: 11 WALL STREET
CITY: NEW YORK
STATE: NY
ZIP: 10005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Enfusion, Inc.
CENTRAL INDEX KEY: 0001868912
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 125 SOUTH CLARK STREET, SUITE 750
CITY: CHICAGO
STATE: IL
ZIP: 60603
BUSINESS PHONE: (312) 253-9800
MAIL ADDRESS:
STREET 1: 125 SOUTH CLARK STREET, SUITE 750
CITY: CHICAGO
STATE: IL
ZIP: 60603
4
1
tm2323724-6_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-08-11
0
0001868912
Enfusion, Inc.
ENFN
0001276505
LEIBOWITZ LAWRENCE E
C/O ENFUSION, INC.
125 SOUTH CLARK STREET SUITE 750
CHICAGO
IL
60603
1
0
0
0
0
Class A Common Stock
2023-08-11
4
A
0
1332
0
A
145414
D
Consists of fully vested shares issued under the Enfusion, Inc. 2021 Stock Option and Incentive Plan in connection with the previously disclosed pre-IPO termination of the Enfusion Ltd. LLC Change in Control Bonus Plan.
/s/ Matthew Campobasso, as Attorney-in-Fact
2023-08-15